FOXO3 and prostate cancer: Similar to previous studies on breast and prostate cancer [32], [33], we found, using qRT-PCR and western blotting analysis, that FOXO3a expression was decreased at the mRNA and protein levels, respectively, in most tumor tissues compared to their adjacent non-tumorous tissues.